Price Chart

Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
URL https://www.astrazeneca.com
Investor Relations URL https://www.astrazeneca.com/investor-relations.html
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Large Cap/Growth
Next Earnings Release Nov. 12, 2024
Last Earnings Release Jul. 25, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 09, 2024

Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
URL https://www.astrazeneca.com
Investor Relations URL https://www.astrazeneca.com/investor-relations.html
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Large Cap/Growth
Next Earnings Release Nov. 12, 2024
Last Earnings Release Jul. 25, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 09, 2024